![](/img/cover-not-exists.png)
PMS39 COST-EFFECTIVENESS OF RITUXIMAB VERSUS ALTERNATIVE ANTI-TUMOR NECROSIS FACTOR (TNF) THERAPY AFTER PREVIOUS FAILURE OF ONE ANTI-TNF AGENT FOR TREATMENT OF RHEUMATOID ARTHRITIS IN COSTA RICA
F CarlosVolume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(11)72192-1
File:
PDF, 68 KB
english, 2010